Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial.
Ogihara Y, Yamada N, Izumi D, Sato Y, Sato T, Nakaya H, Mori T, Ota S, Makino M, Ogura T, Tamaru S, Nishimura Y, Tanigawa T, Kasai A, Nishikawa M, Dohi K; ISE CALF DVT Study Investigators. Ogihara Y, et al. Among authors: nakaya h. Res Pract Thromb Haemost. 2024 Jul 14;8(5):102515. doi: 10.1016/j.rpth.2024.102515. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39188889 Free PMC article.
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa S; J-RHYTHM II Investigators. Yamashita T, et al. Among authors: nakaya h. Europace. 2011 Apr;13(4):473-9. doi: 10.1093/europace/euq439. Epub 2010 Dec 10. Europace. 2011. PMID: 21148662 Clinical Trial.
The single-cell transcriptome of mTECs and CD4+ thymocytes under adhesion revealed heterogeneity of mTECs and a network controlled by Aire and lncRNAs.
Monteiro CJ, Duarte MJ, Machado MCV, Mascarenhas RS, Palma PVB, García HDM, Nakaya HI, Cunha TM, Donadi EA, Passos GA. Monteiro CJ, et al. Among authors: nakaya hi. Front Immunol. 2024 Aug 26;15:1376655. doi: 10.3389/fimmu.2024.1376655. eCollection 2024. Front Immunol. 2024. PMID: 39328409 Free PMC article.
The global evolution and impact of systems biology and artificial intelligence in stem cell research and therapeutics development: a scoping review.
Silva-Sousa T, Usuda JN, Al-Arawe N, Frias F, Hinterseher I, Catar R, Luecht C, Riesner K, Hackel A, Schimke LF, Dias HD, Filgueiras IS, Nakaya HI, Camara NOS, Fischer S, Riemekasten G, Ringdén O, Penack O, Winkler T, Duda G, Fonseca DLM, Cabral-Marques O, Moll G. Silva-Sousa T, et al. Among authors: nakaya hi. Stem Cells. 2024 Nov 5;42(11):929-944. doi: 10.1093/stmcls/sxae054. Stem Cells. 2024. PMID: 39230167 Review.
Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon.
Alabi A, Kokou K, Mahmoudou S, Kavishna R, Nakka SS, Rothenberger S, Musangomunei FP, Olubiyi BF, Bie-Ondo JC, Kabwende AL, Velavan TP; VSV-EBOPLUS Consortium; Medaglini D, Nakaya HI, Engler O, Harandi AM, Siegrist CA, Kremsner PG, Agnandji ST. Alabi A, et al. Among authors: nakaya hi. J Infect. 2024 Oct;89(4):106237. doi: 10.1016/j.jinf.2024.106237. Epub 2024 Aug 8. J Infect. 2024. PMID: 39121969 Free article. Clinical Trial.
501 results